Table of Contents Table of Contents
Previous Page  234 320 Next Page
Information
Show Menu
Previous Page 234 320 Next Page
Page Background

Statistical analysis:

None.

Obtaining funding:

None.

Administrative, technical, or material support:

None.

Supervision:

Knoll, Tu¨ rk, Ruhayel, Dabestani.

Other:

None.

Financial disclosures:

Thomas Knoll certifies that all conflicts of interest,

including specific financial interests and relationships and affiliations

relevant to the subject matter or materials discussed in the manuscript

(eg, employment/affiliation, grants or funding, consultancies, honoraria,

stock ownership or options, expert testimony, royalties, or patents filed,

received, or pending), are the following: Alesˇ Petrˇı´k has received speaker

honoraria from GSK and fellowship and travel grants from Astellas and

Olympus. Christian Seitz has received consultant fees from Astellas and

speaker honoraria from Rowa Wagner. Michael Straub has received

consultant fees from Richard Wolf Endoskope and Sanochemia

Pharmazeutika. Thomas Knoll has received consultant fees from

Schoelly, Boston Scientific, Olympus, and Storz Medical, and speaker

honoraria from Karl Storz, Richard Wolf, Olympus, Boston Scientific, and

Ibsen; and has participated in trials by Cook and Coloplast. The

remaining authors have nothing to disclose.

Funding/Support and role of the sponsor:

None.

Acknowledgments:

We are grateful for the valuable help of Karin Plass,

European Association of Urology Guidelines Office, Arnhem, The

Netherlands, for providing administrative support. We also thank

Richard Sylvester and Thomas Lam, of the EAU Guidelines Office, for

providing methodological supervision and support.

References

[1]

Hesse A, Brandle E, Wilbert D, Kohrmann KU, Alken P. Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000. Eur Urol 2003;44:709–13.

[2]

Lotan Y, Buendia Jimenez I, Lenoir-Wijnkoop I, et al. Primary prevention of nephrolithiasis is cost-effective for a national health- care system. BJU Int 2012;110:E1060–7.

[3]

Scales Jr CD, Smith AC, Hanley JM, et al. Prevalence of kidney stones in the United States. Eur Urol 2012;62:160–5.

[4]

Tu¨ rk C, Knoll T, Petrˇı´k A, et al. EAU guidelines on urolithiasis 2014. Arnhem, The Netherlands: European Association of Urology; 2014.

[5]

Preminger GM, Assimos DG, Lingeman JE, et al. Chapter 1: AUA guideline on management of staghorn calculi: diagnosis and treat- ment recommendations. J Urol 2005;173:1991–2000.

[6]

Jackman SV, Docimo SG, Cadeddu JA, Bishoff JT, Kavoussi LR, Jarrett TW. The ‘‘mini-perc’’ technique: a less invasive alternative to percutaneous nephrolithotomy. World J Urol 1998;16:371–4.

[7]

Helal M, Black T, Lockhart J, Figueroa TE. The Hickman peel-away sheath: alternative for pediatric percutaneous nephrolithotomy. J Endourol 1997;11:171–2.

[8]

Desai J, Solanki R. Ultra-mini percutaneous nephrolithotomy (UMP): one more armamentarium. BJU Int 2013;112:1046–9.

[9]

Desai MR, Sharma R, Mishra S, Sabnis RB, Stief C, Bader M. Single- step percutaneous nephrolithotomy (microperc): the initial clinical report. J Urol 2011;186:140–5.

[10]

Kukreja R, Desai M, Patel S, Bapat S, Desai M. Factors affecting blood loss during percutaneous nephrolithotomy: prospective study. J Endourol 2004;18:715–22

.

[11]

Giusti G, Piccinelli A, Taverna G, et al. Miniperc? No, thank you! Eur Urol 2007;51:810–4.

[12]

Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9.

[13] Higgins JP, Green S. Cochrane handbook for systematic reviews of

interventions. The Cochrane Collaboration; 2011.

[14]

Deeks JJ, Dinnes J, D’Amico R, et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003;7:1–173

.

[15] Reeves BC, Deeks JJ, Higgins JP, Wells GA. Including non-random-

ised studies. In: Higgins JP, Green S, editors. Cochrane handbook for

systematic reviews of interventions. The Cochrane Collaboration;

2011. Chapter 13.

[16]

Dalziel K, Round A, Stein K, Garside R, Castelnuovo E, Payne L. Do the findings of case series studies vary significantly according to methodological characteristics? Health Technol Assess 2005;9: 1–146.

[17] Viswanathan M, Ansari MT, Berkman ND, et al. Assessing the risk of

bias of individual studies in systematic reviews of health care

interventions. Rockville, MD: Agency for Healtcare Research and

Quality; 2008.

[18]

Abdelhafez MF, Amend B, Bedke J, et al. Minimally invasive percu- taneous nephrolithotomy: a comparative study of the management of small and large renal stones. Urology 2013;81:241–5.

[19]

Cheng F, Yu W, Zhang X, Yang S, Xia Y, Ruan Y. Minimally invasive tract in percutaneous nephrolithotomy for renal stones. J Endourol 2010;24:1579–82.

[20]

Desai J, Zeng G, Zhao Z, Zhong W, Chen W, WuW. A novel technique of ultra-mini-percutaneous nephrolithotomy: introduction and an initial experience for treatment of upper urinary calculi less than 2 cm. Biomed Res Int 2013;2013:490793.

[21]

Karakose A, Aydogdu O, Atesci YZ. The use of the Amplatz sheath in percutaneous nephrolithotomy: does Amplatz sheath size matter? Curr Urol 2013;7:127–31

.

[22]

Knoll T, Wezel F, Michel MS, Honeck P, Wendt-Nordahl G. Do patients benefit from miniaturized tubeless percutaneous nephro- lithotomy?. A comparative prospective study. J Endourol 2010;24:1075–9

.

[23]

Lu Y, Ping JG, Zhao XJ, Hu LK, Pu JX. Randomized prospective trial of tubeless versus conventional minimally invasive percutaneous nephrolithotomy. World J Urol 2013;31:1303–7.

[24]

Mishra S, Sharma R, Garg C, Kurien A, Sabnis R, Desai M. Prospective comparative study of miniperc and standard PNL for treatment of 1 to 2 cm size renal stone. BJU Int 2011;108:896–9

.

[25]

Sung YM, Chod SW, Jeon SS, Shin SW, Park KB, Do YS. The ‘‘mini- perc’’ technique of percutaneous nephrolithotomy with a 14-Fr peel-away sheath: 3-year results in 72 patients. Korean J Radiol 2006;7:103–6.

[26]

Xu S, Shi H, Zhu J, et al. A prospective comparative study of haemodynamic, electrolyte, and metabolic changes during percu- taneous nephrolithotomy and minimally invasive percutaneous nephrolithotomy. World J Urol 2014;32:1275–80.

[27]

Yamaguchi A, Skolarikos A, Buchholz NPN, et al. Operating times and bleeding complications in percutaneous nephrolithotomy: a comparison of tract dilation methods in 5537 patients in the Clinical Research Office of the Endourological Society percutaneous nephrolithotomy global study. J Endourol 2011;25:947–54

.

[28]

Tepeler A, Akman T, Silay MS, et al. Comparison of intrarenal pelvic pressure during micro-percutaneous nephrolithotomy and conven- tional percutaneous nephrolithotomy. Urolithiasis 2014;42:275–9

.

[29]

Bhattu A, Mohan V, Jagtap J, et al. Miniperc: 301 cases single centre experience and outcome analysis. Indian J Urol 2014;30:S64

.

[30]

Desai J, Solanki R. Ultra-mini PCNL (UMP). Eur Urol Suppl 2013;12: eV40.

[31]

Karatag T, Buldu I, Inan R, Istanbulluoglu MO. The treatment of moderate size renal calculi with micro-percutaneous nephrolithot- omy technique: our clinical experiences. Eur Urol Suppl 2014;13: e614

.

E U R O P E A N U R O L O G Y 7 2 ( 2 0 1 7 ) 2 2 0 – 2 3 5

234